These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6797740)

  • 1. Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1981 Nov; 65(1):115-30. PubMed ID: 6797740
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic potential of mouse spleen cells on H-2 antibody-treated target cells.
    Kiessling R; Klein E
    J Exp Med; 1973 Feb; 137(2):527-32. PubMed ID: 4631140
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency determination of killer cells by a single-cell cytotoxic assay.
    Bonavida B; Bradley TP; Grimm EA
    Methods Enzymol; 1983; 93():270-80. PubMed ID: 6408349
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of natural cytotoxicity by alloantibodies. IV. A comparative study of the activation of mouse spleen cell cytotoxicity by anti H-2 antisera, interferon, and mitogens.
    Saxena RK; Adler WH; Nordin AA
    Cell Immunol; 1981 Sep; 63(1):28-41. PubMed ID: 6168393
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor immunity in B-lymphocyte-deprived mice. II. In vitro studies.
    Brodt P; Gordon J
    Cell Immunol; 1981 Nov; 65(1):20-32. PubMed ID: 6976212
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC; Reynolds CW; Herberman RB
    Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the murine NK cell as to structure, function and biological relevance.
    Kiessling R; Wigzell H
    Immunol Rev; 1979; 44():165-208. PubMed ID: 367949
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens.
    Kato I; Yokokura T; Mutai M
    Microbiol Immunol; 1984; 28(2):209-17. PubMed ID: 6427563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human E-rosette-positive cells which bind monomeric IgG mediate natural cytotoxicity.
    Froelich CJ; Tai AS; Bankhurst AD; Warner NL
    Cell Immunol; 1982 Jan; 66(1):190-4. PubMed ID: 7083331
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of natural cytotoxicity by alloantibodies. III. Augmentation of natural killer activity by alloantisera directed against K, D, and I regions of the murine H-2 complex.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1980 Nov; 56(1):89-98. PubMed ID: 7428057
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural cytotoxicity to human leukemia mediated by mouse non-T cells.
    Haller O; Kiessling R; Orn A; Kärre K; Nilsson K; Wigzell H
    Int J Cancer; 1977 Jul; 20(1):93-103. PubMed ID: 903185
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural cytotoxicity in the mouse embryo. I. Evidence for the presence of natural cytotoxic function in the yolk sac of the 10-day mouse embryo.
    Dahl CA
    J Immunol; 1980 Nov; 125(5):1924-7. PubMed ID: 6776183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.
    Laatikainen A; Karjalainen H; Jägerroos H; Sarkkinen H; Mäntyjärvi R
    Cancer Immunol Immunother; 1990; 31(3):164-8. PubMed ID: 2159847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.
    Haller O; Hansson M; Kiessling R; Wigzell H
    Nature; 1977 Dec; 270(5638):609-11. PubMed ID: 593386
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential lysis of endogenous and activated natural killer cells by anti-NK-1.2 antibody and complement.
    Kumar V; Barnes MC; Bennett M; Burton RC
    J Immunol; 1982 Mar; 128(3):1482-4. PubMed ID: 6173440
    [No Abstract]   [Full Text] [Related]  

  • 19. Physico-chemical characteristics of tumour cells susceptible to lysis by natural killer (NK) cells.
    Becker S; Stendahl O; Magnusson KE
    Immunol Commun; 1979; 8(1):73-83. PubMed ID: 105988
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.
    Ratliff TL; McCool RE; Catalona WJ
    Cell Immunol; 1981 Jan; 57(1):1-12. PubMed ID: 6163551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.